John Cavan

Insider Reports History

Location
New York, NY
Signature
/s/ John Cavan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Cavan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Hepion Pharmaceuticals, Inc. Chief Financial Officer Stock Options 1,581,060 18 May 2021 Direct

Insider Reports Filed by John Cavan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HEPA Hepion Pharmaceuticals, Inc. 18 May 2021 1 $0 4 Chief Financial Officer 20 May 2021, 16:35